日本荣研化学株社会 Eiken Chemical 
拥有70年历史的日本荣研化学株社会社是日本东京证券交易所一部上市公司，主要从事体外诊断试剂盒、医疗器械和基因检测制品的研发、生产、销售。是日本该领域最大，也是全球领先的企业之一。
由荣研化学株社会社全资建立的荣研生物科技（上海）有限公司集研发中心、生产基地为一体、于2006年11月在上海张江高科技园区正式启动运营。

北京蓝谱生物科技有限公司是经正式授权的日本荣研化学株式会社LAMP法相关产品在中国(包括港澳)地区的总经销代理企业，是经国家相关部门批准注册的企业。主营LAMP（环介导等温扩增法）仪器及试剂，以及相关咨询合作业务，公司总部位于北京市海淀区中关村南大街10号银海大厦南315室，上海办事处位于上海市浦东新区哈雷路1058号（荣研生物科技（中国）有限公司内4F）

EIKEN CHEMICAL CO., LTD., from its foundation in 1939, has been committed to contributing to public health and the prevention of epidemics. In 1949, we became the first Japanese company to successfully commercialize the manufacture of powdered culture media for microbiological investigations.

In addition to microbiological diagnosis, we have played an active role in medical progress and public health through the development of clinical diagnostic aids vital to various aspects of contemporary medicine, including biochemical, immunological, serological, dry chemical diagnosis, and automatic analyzers.

In 1998, EIKEN CHEMICAL developed an innovative nucleic acid amplification method, definite “LAMP” (Loop-mediated Isothermal Amplification).

With its advantages over conventional methods, it is inevitable that the LAMP method will be applied extensively across a variety of fields due to its outstanding characteristics as an innovative genetic testing procedure.

In September, 2004, EIKEN CHEMICAL established EIKEN SHANGHAI CO., LTD. in China, and in April, 2007, merged EIKEN KIZAI CO., LTD. which was a previously subsidiary. We will expand our business and utilize our financial resources effectively.

Clinical diagnosis is expected to grow in importance as a result of rising public demand for healthier living, and the prevention and early diagnosis of lifestyle-related diseases.

EIKEN CHEMICAL has established itself as a leader in the clinical diagnostics market, and will maintain its commitment to public health through the development of products and technologies that fill needs at the cutting edge of contemporary medicine.